23 Oct 2024
// FDA
15 Aug 2024
// PRESS RELEASE
08 Aug 2024
// PRESS RELEASE
01 2ACETAZOLAMIDE
02 6AMITRIPTYLINE HYDROCHLORIDE
03 2APIXABAN
04 6ARIPIPRAZOLE
05 3ASENAPINE MALEATE
06 2BENDAMUSTINE HYDROCHLORIDE
07 1BRETYLIUM TOSYLATE
08 1CABAZITAXEL
09 2CARFILZOMIB
10 3CLOBAZAM
11 2DABIGATRAN ETEXILATE MESYLATE
12 4DULOXETINE HYDROCHLORIDE
13 2ENTECAVIR
14 1EPINASTINE HYDROCHLORIDE
15 2EPLERENONE
16 2ESTRADIOL; NORETHINDRONE ACETATE
17 7EVEROLIMUS
18 1EXEMESTANE
19 2IMATINIB MESYLATE
20 1LAMIVUDINE
21 2LANSOPRAZOLE
22 2METHSCOPOLAMINE BROMIDE
23 1METHYLERGONOVINE MALEATE
24 2METHYLPHENIDATE HYDROCHLORIDE
25 1MIGLUSTAT
26 1MONTELUKAST SODIUM
27 1NOREPINEPHRINE BITARTRATE
28 3OMEPRAZOLE
29 3OXCARBAZEPINE
30 1PENICILLAMINE
31 2PIROXICAM
32 1POLYETHYLENE GLYCOL 3350
33 4POMALIDOMIDE
34 2POTASSIUM CHLORIDE
35 3RIVASTIGMINE
36 2ROFLUMILAST
37 2SOLIFENACIN SUCCINATE
38 1SUCCINYLCHOLINE CHLORIDE
39 1TERBINAFINE HYDROCHLORIDE
40 2TERIFLUNOMIDE
41 2TETRACYCLINE HYDROCHLORIDE
42 1TOFACITINIB
43 3TRIMIPRAMINE MALEATE
44 1ZOLEDRONIC ACID
45 2ZOLPIDEM TARTRATE
01 9CAPSULE, DELAYED REL PELLETS;ORAL
02 15CAPSULE;ORAL
03 3FILM, EXTENDED RELEASE;TRANSDERMAL
04 1FOR SOLUTION;ORAL
05 4INJECTABLE;INJECTION
06 1INJECTABLE;INTRAVENOUS
07 2POWDER;INTRAVENOUS
08 2POWDER;IV (INFUSION)
09 1SOLUTION/DROPS;OPHTHALMIC
10 1SOLUTION;INTRAVENOUS
11 2SOLUTION;ORAL
12 4TABLET, EXTENDED RELEASE;ORAL
13 50TABLET;ORAL
14 3TABLET;SUBLINGUAL
01 10.05%
02 10.25MG
03 10.2MG/ML
04 20.5MG
05 10.5MG;0.1MG
06 10.75MG
07 2100MG
08 1100MG/VIAL
09 110MEQ
10 710MG
11 110MG/5ML
12 110MG/VIAL
13 1110MG
14 112.5MG
15 1125MG
16 113.3MG/24HR
17 114MG
18 4150MG
19 215MG
20 117GM/SCOOPFUL
21 21MG
22 11MG;0.5MG
23 32.5MG
24 120MEQ
25 420MG
26 120MG/ML
27 1250MCG
28 3250MG
29 325MG
30 125MG/VIAL
31 22MG
32 1300MG
33 230MG
34 13MG
35 14.6MG/24HR
36 140MG
37 14MG
38 1500MCG
39 1500MG
40 250MG
41 150MG/ML
42 75MG
43 15MG/5ML
44 16.25MG
45 1600MG
46 160MG/1.5ML (40MG/ML)
47 160MG/VIAL
48 17.5MG
49 175MG
50 17MG
51 19.5MG/24HR
52 2EQ 100MG BASE
53 2EQ 10MG BASE
54 1EQ 1MG BASE/ML
55 1EQ 2.5MG BASE
56 1EQ 20MG BASE
57 1EQ 250MG BASE
58 1EQ 25MG BASE
59 1EQ 30MG BASE
60 1EQ 400MG BASE
61 1EQ 40MG BASE
62 1EQ 4MG BASE/5ML
63 1EQ 50MG BASE
64 1EQ 5MG BASE
65 1EQ 60MG BASE
01 42DISCN
02 53RX
03 3Blank
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAZOLAMIDE
Dosage Strength : 125MG
Approval Date : 2020-04-30
Application Number : 207503
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAZOLAMIDE
Dosage Strength : 250MG
Approval Date : 2020-04-30
Application Number : 207503
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 10MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 25MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 50MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 75MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 100MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 150MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : APIXABAN
Dosage Strength : 2.5MG
Approval Date : 2021-07-26
Application Number : 209845
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : APIXABAN
Dosage Strength : 5MG
Approval Date : 2021-07-26
Application Number : 209845
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LOOKING FOR A SUPPLIER?